ClinChoice is proud to announce the successful completion and approval of its ISO 9001:2015 and ISO 14155:2020 ...

First-of-a-kind health economics study found lifetime per-patient savings from early TAVR range from £1,788 in the UK to CHF ...

The Global Breath Analyzers Market is projected to grow at a CAGR of approximately 15-17% by 2027. Key factors fueling this ...

The Global ESG Reporting Market is projected to experience robust growth, with an estimated annual growth rate of around 15% ...

LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 18, 2025 / As we observe National Diabetes Month, St. Joseph Medical is proud to highlight some of the inspiring journeys of patients who have ...

New Zealand Policy Management in Telecom MarketThe New Zealand policy management in telecom market is built on transparency, ...

UK research organisations receive funding to extract Lead-212 from spent uranium fuel for targeted alpha therapy, aiming to ...

A Colorado surgeon's groundbreaking reconstruction rebuilds a child's eyelids, rescues her sight, and transforms a once-hopeless diagnosis into a life filled with possibility and a second chance at ...

Total capital raised across Sofinnova’s platform reaches €1.5Bn over the past yearSofinnova Capital XI is actively investing in early-stage biotech and medtech companies across Europe and the USPARIS, ...

EXTON, PA / ACCESS Newswire / November 18, 2025 / AideChoice, a pioneering app-based platform connecting individuals with trusted short-term non-medical home care services, today announced its ...

Is a Serious, Progressive Lung Disease That Can Lead to Permanent Lung Damage[i] — BRINSUPRI Is a First-in-Disease, First-in-Class DPP1 Inhibitor Targeting Neutrophilic Inflammation — BRINSUPRI Was ...

A North Wales pharmaceutical manufacturer backed by the Development Bank of Wales is accelerating its global expansion by launching two new products and unveiling plans to extend its global ...